338 related articles for article (PubMed ID: 18846251)
21. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
22. Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cells.
Fehr T; Wang S; Haspot F; Kurtz J; Blaha P; Hogan T; Chittenden M; Wekerle T; Sykes M
J Immunol; 2008 Sep; 181(6):4371-80. PubMed ID: 18768896
[TBL] [Abstract][Full Text] [Related]
23. Differential susceptibility of allogeneic targets to indirect CD4 immunity generates split tolerance.
Chan WF; Razavy H; Anderson CC
J Immunol; 2008 Oct; 181(7):4603-12. PubMed ID: 18802062
[TBL] [Abstract][Full Text] [Related]
24. Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo.
Wong W; Billing JS; Stranford SA; Hyde K; Fry J; Morris PJ; Wood KJ
Hum Gene Ther; 2003 Apr; 14(6):577-90. PubMed ID: 12718767
[TBL] [Abstract][Full Text] [Related]
25. Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts.
Ensminger SM; Spriewald BM; Witzke O; Morrison K; Pajaro OE; Morris PJ; Rose ML; Wood KJ
Transplantation; 2002 Apr; 73(7):1068-74. PubMed ID: 11965033
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
[TBL] [Abstract][Full Text] [Related]
28. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
Herrera OB; Brett S; Lechler RI
Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
Yamazaki S; Inaba K; Tarbell KV; Steinman RM
Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
[TBL] [Abstract][Full Text] [Related]
30. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW
J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751
[TBL] [Abstract][Full Text] [Related]
31. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
Kupfer TM; Crawford ML; Pham K; Gill RG
J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
[TBL] [Abstract][Full Text] [Related]
32. Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance.
Dangi A; Sumpter TL; Kimura S; Stolz DB; Murase N; Raimondi G; Vodovotz Y; Huang C; Thomson AW; Gandhi CR
J Immunol; 2012 Apr; 188(8):3667-77. PubMed ID: 22427640
[TBL] [Abstract][Full Text] [Related]
33. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex.
Fujio K; Misaki Y; Setoguchi K; Morita S; Kawahata K; Kato I; Nosaka T; Yamamoto K; Kitamura T
J Immunol; 2000 Jul; 165(1):528-32. PubMed ID: 10861092
[TBL] [Abstract][Full Text] [Related]
34. Co-receptor-independent signal transduction in a mismatched CD8+ major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte.
Eshima K; Tachibana M; Suzuki H; Yamazaki S; Shinohara N
Eur J Immunol; 1997 Jan; 27(1):55-61. PubMed ID: 9021998
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of allogeneic cytotoxic T cell (CD8
Kang N; Toyofuku WM; Yang X; Scott MD
Acta Biomater; 2017 Jul; 57():146-155. PubMed ID: 28442414
[TBL] [Abstract][Full Text] [Related]
36. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.
Boisgérault F; Liu Y; Anosova N; Ehrlich E; Dana MR; Benichou G
J Immunol; 2001 Aug; 167(4):1891-9. PubMed ID: 11489968
[TBL] [Abstract][Full Text] [Related]
37. CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance.
Jiang S; Lechler RI; He XS; Huang JF
Expert Opin Biol Ther; 2006 Oct; 6(10):1003-9. PubMed ID: 16989582
[TBL] [Abstract][Full Text] [Related]
38. A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriers.
Koch U; Korngold R
Blood; 1997 Apr; 89(8):2880-90. PubMed ID: 9108408
[TBL] [Abstract][Full Text] [Related]
39. Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.
Smyth LA; Ratnasothy K; Moreau A; Alcock S; Sagoo P; Meader L; Tanriver Y; Buckland M; Lechler R; Lombardi G
J Immunol; 2013 May; 190(9):4848-60. PubMed ID: 23536635
[TBL] [Abstract][Full Text] [Related]
40. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
